nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—acquired immunodeficiency syndrome	0.219	1	CbGaD
Rosiglitazone—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0326	0.0547	CbGbCtD
Rosiglitazone—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0296	0.0497	CbGbCtD
Rosiglitazone—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0288	0.0483	CbGbCtD
Rosiglitazone—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.026	0.0437	CbGbCtD
Rosiglitazone—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.026	0.0437	CbGbCtD
Rosiglitazone—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0214	0.0359	CbGbCtD
Rosiglitazone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0145	0.0244	CbGbCtD
Rosiglitazone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0145	0.0244	CbGbCtD
Rosiglitazone—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0143	0.0241	CbGbCtD
Rosiglitazone—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0239	CbGbCtD
Rosiglitazone—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0137	0.0229	CbGbCtD
Rosiglitazone—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0135	0.0226	CbGbCtD
Rosiglitazone—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0132	0.0222	CbGbCtD
Rosiglitazone—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0124	0.0209	CbGbCtD
Rosiglitazone—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0124	0.0209	CbGbCtD
Rosiglitazone—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0122	0.0205	CbGbCtD
Rosiglitazone—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0122	0.0205	CbGbCtD
Rosiglitazone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0119	0.02	CbGbCtD
Rosiglitazone—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0112	0.0189	CbGbCtD
Rosiglitazone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0112	0.0188	CbGbCtD
Rosiglitazone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0112	0.0188	CbGbCtD
Rosiglitazone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.011	0.0185	CbGbCtD
Rosiglitazone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0185	CbGbCtD
Rosiglitazone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0109	0.0183	CbGbCtD
Rosiglitazone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0106	0.0177	CbGbCtD
Rosiglitazone—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0105	0.0177	CbGbCtD
Rosiglitazone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0102	0.0172	CbGbCtD
Rosiglitazone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0102	0.0172	CbGbCtD
Rosiglitazone—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0102	0.0171	CbGbCtD
Rosiglitazone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0101	0.017	CbGbCtD
Rosiglitazone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0101	0.017	CbGbCtD
Rosiglitazone—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00943	0.0158	CbGbCtD
Rosiglitazone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00927	0.0156	CbGbCtD
Rosiglitazone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00927	0.0156	CbGbCtD
Rosiglitazone—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00924	0.0155	CbGbCtD
Rosiglitazone—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00924	0.0155	CbGbCtD
Rosiglitazone—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00886	0.0149	CbGbCtD
Rosiglitazone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00875	0.0147	CbGbCtD
Rosiglitazone—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00853	0.0143	CbGbCtD
Rosiglitazone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00849	0.0143	CbGbCtD
Rosiglitazone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.008	0.0134	CbGbCtD
Rosiglitazone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00777	0.013	CbGbCtD
Rosiglitazone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00768	0.0129	CbGbCtD
Rosiglitazone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00768	0.0129	CbGbCtD
Rosiglitazone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00736	0.0124	CbGbCtD
Rosiglitazone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00702	0.0118	CbGbCtD
Rosiglitazone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00702	0.0118	CbGbCtD
Rosiglitazone—ACSL4—retina—acquired immunodeficiency syndrome	0.00172	0.0456	CbGeAlD
Rosiglitazone—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00163	0.0435	CbGeAlD
Rosiglitazone—PPARG—endothelium—acquired immunodeficiency syndrome	0.00159	0.0422	CbGeAlD
Rosiglitazone—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00141	0.0375	CbGeAlD
Rosiglitazone—ACSL4—digestive system—acquired immunodeficiency syndrome	0.00121	0.032	CbGeAlD
Rosiglitazone—ACSL4—blood—acquired immunodeficiency syndrome	0.00115	0.0305	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—acquired immunodeficiency syndrome	0.00111	0.0295	CbGeAlD
Rosiglitazone—ACSL4—spinal cord—acquired immunodeficiency syndrome	0.00111	0.0294	CbGeAlD
Rosiglitazone—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00107	0.0283	CbGeAlD
Rosiglitazone—ACSL4—vagina—acquired immunodeficiency syndrome	0.00106	0.0283	CbGeAlD
Rosiglitazone—ACSL4—lung—acquired immunodeficiency syndrome	0.00101	0.0268	CbGeAlD
Rosiglitazone—ACSL4—nervous system—acquired immunodeficiency syndrome	0.000932	0.0248	CbGeAlD
Rosiglitazone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00093	0.0247	CbGeAlD
Rosiglitazone—ACSL4—central nervous system—acquired immunodeficiency syndrome	0.000897	0.0239	CbGeAlD
Rosiglitazone—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00087	0.0231	CbGeAlD
Rosiglitazone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000849	0.0226	CbGeAlD
Rosiglitazone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000826	0.022	CbGeAlD
Rosiglitazone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000754	0.02	CbGeAlD
Rosiglitazone—ACSL4—brain—acquired immunodeficiency syndrome	0.000712	0.0189	CbGeAlD
Rosiglitazone—ACSL4—lymph node—acquired immunodeficiency syndrome	0.000688	0.0183	CbGeAlD
Rosiglitazone—PPARG—skin of body—acquired immunodeficiency syndrome	0.000678	0.018	CbGeAlD
Rosiglitazone—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000629	0.0167	CbGeAlD
Rosiglitazone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00062	0.0165	CbGeAlD
Rosiglitazone—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000599	0.0159	CbGeAlD
Rosiglitazone—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000562	0.015	CbGeAlD
Rosiglitazone—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000549	0.0146	CbGeAlD
Rosiglitazone—PPARG—digestive system—acquired immunodeficiency syndrome	0.000542	0.0144	CbGeAlD
Rosiglitazone—CYP2A6—lung—acquired immunodeficiency syndrome	0.000532	0.0141	CbGeAlD
Rosiglitazone—PPARG—blood—acquired immunodeficiency syndrome	0.000517	0.0137	CbGeAlD
Rosiglitazone—PPARG—bone marrow—acquired immunodeficiency syndrome	0.0005	0.0133	CbGeAlD
Rosiglitazone—PPARG—vagina—acquired immunodeficiency syndrome	0.000479	0.0127	CbGeAlD
Rosiglitazone—PPARG—lung—acquired immunodeficiency syndrome	0.000453	0.012	CbGeAlD
Rosiglitazone—PPARG—nervous system—acquired immunodeficiency syndrome	0.000419	0.0112	CbGeAlD
Rosiglitazone—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00041	0.0109	CbGeAlD
Rosiglitazone—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000404	0.0107	CbGeAlD
Rosiglitazone—CYP2C19—blood—acquired immunodeficiency syndrome	0.00039	0.0104	CbGeAlD
Rosiglitazone—CYP2A6—brain—acquired immunodeficiency syndrome	0.000376	0.01	CbGeAlD
Rosiglitazone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000362	0.00964	CbGeAlD
Rosiglitazone—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000362	0.00962	CbGeAlD
Rosiglitazone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000341	0.00905	CbGeAlD
Rosiglitazone—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000335	0.00889	CbGeAlD
Rosiglitazone—PPARG—brain—acquired immunodeficiency syndrome	0.000321	0.00852	CbGeAlD
Rosiglitazone—CYP1A2—blood—acquired immunodeficiency syndrome	0.000319	0.00847	CbGeAlD
Rosiglitazone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000318	0.00844	CbGeAlD
Rosiglitazone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000316	0.00839	CbGeAlD
Rosiglitazone—PPARG—lymph node—acquired immunodeficiency syndrome	0.00031	0.00824	CbGeAlD
Rosiglitazone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000302	0.00804	CbGeAlD
Rosiglitazone—ALB—brain—acquired immunodeficiency syndrome	0.000301	0.00799	CbGeAlD
Rosiglitazone—ALB—lymph node—acquired immunodeficiency syndrome	0.000291	0.00773	CbGeAlD
Rosiglitazone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00029	0.00771	CbGeAlD
Rosiglitazone—CYP1A2—lung—acquired immunodeficiency syndrome	0.000279	0.00743	CbGeAlD
Rosiglitazone—PTGS1—blood—acquired immunodeficiency syndrome	0.000276	0.00734	CbGeAlD
Rosiglitazone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000266	0.00707	CbGeAlD
Rosiglitazone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000256	0.00681	CbGeAlD
Rosiglitazone—PTGS1—lung—acquired immunodeficiency syndrome	0.000242	0.00644	CbGeAlD
Rosiglitazone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000238	0.00634	CbGeAlD
Rosiglitazone—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000234	0.00158	CcSEcCtD
Rosiglitazone—Infection—Abacavir—acquired immunodeficiency syndrome	0.000234	0.00158	CcSEcCtD
Rosiglitazone—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.00157	CcSEcCtD
Rosiglitazone—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00157	CcSEcCtD
Rosiglitazone—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00157	CcSEcCtD
Rosiglitazone—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00156	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00156	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00156	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00156	CcSEcCtD
Rosiglitazone—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00155	CcSEcCtD
Rosiglitazone—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00155	CcSEcCtD
Rosiglitazone—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00154	CcSEcCtD
Rosiglitazone—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00154	CcSEcCtD
Rosiglitazone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000227	0.00604	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00153	CcSEcCtD
Rosiglitazone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000224	0.00596	CbGeAlD
Rosiglitazone—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00151	CcSEcCtD
Rosiglitazone—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00151	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00151	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00149	CcSEcCtD
Rosiglitazone—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00148	CcSEcCtD
Rosiglitazone—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00148	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.00148	CcSEcCtD
Rosiglitazone—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00148	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000218	0.00147	CcSEcCtD
Rosiglitazone—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00147	CcSEcCtD
Rosiglitazone—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00147	CcSEcCtD
Rosiglitazone—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000217	0.00147	CcSEcCtD
Rosiglitazone—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00146	CcSEcCtD
Rosiglitazone—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00146	CcSEcCtD
Rosiglitazone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000216	0.00574	CbGeAlD
Rosiglitazone—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00145	CcSEcCtD
Rosiglitazone—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00145	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00145	CcSEcCtD
Rosiglitazone—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00145	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000214	0.00145	CcSEcCtD
Rosiglitazone—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000214	0.00145	CcSEcCtD
Rosiglitazone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000214	0.00144	CcSEcCtD
Rosiglitazone—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00144	CcSEcCtD
Rosiglitazone—CYP2C8—brain—acquired immunodeficiency syndrome	0.000211	0.00562	CbGeAlD
Rosiglitazone—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00143	CcSEcCtD
Rosiglitazone—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00141	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.00141	CcSEcCtD
Rosiglitazone—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.00141	CcSEcCtD
Rosiglitazone—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000207	0.0014	CcSEcCtD
Rosiglitazone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000206	0.00139	CcSEcCtD
Rosiglitazone—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00139	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00139	CcSEcCtD
Rosiglitazone—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00138	CcSEcCtD
Rosiglitazone—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000205	0.00138	CcSEcCtD
Rosiglitazone—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00138	CcSEcCtD
Rosiglitazone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00138	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00138	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000203	0.00138	CcSEcCtD
Rosiglitazone—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00137	CcSEcCtD
Rosiglitazone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000203	0.00137	CcSEcCtD
Rosiglitazone—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00136	CcSEcCtD
Rosiglitazone—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00136	CcSEcCtD
Rosiglitazone—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00134	CcSEcCtD
Rosiglitazone—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00134	CcSEcCtD
Rosiglitazone—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00134	CcSEcCtD
Rosiglitazone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000198	0.00134	CcSEcCtD
Rosiglitazone—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00134	CcSEcCtD
Rosiglitazone—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.00133	CcSEcCtD
Rosiglitazone—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.00132	CcSEcCtD
Rosiglitazone—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000195	0.00132	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000193	0.00131	CcSEcCtD
Rosiglitazone—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000193	0.00131	CcSEcCtD
Rosiglitazone—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.00131	CcSEcCtD
Rosiglitazone—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.0013	CcSEcCtD
Rosiglitazone—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00129	CcSEcCtD
Rosiglitazone—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00129	CcSEcCtD
Rosiglitazone—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.00129	CcSEcCtD
Rosiglitazone—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00129	CcSEcCtD
Rosiglitazone—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00129	CcSEcCtD
Rosiglitazone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000191	0.00129	CcSEcCtD
Rosiglitazone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00019	0.00129	CcSEcCtD
Rosiglitazone—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00019	0.00128	CcSEcCtD
Rosiglitazone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00128	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.00128	CcSEcCtD
Rosiglitazone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000189	0.00128	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00128	CcSEcCtD
Rosiglitazone—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00128	CcSEcCtD
Rosiglitazone—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000189	0.00127	CcSEcCtD
Rosiglitazone—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000187	0.00127	CcSEcCtD
Rosiglitazone—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.00125	CcSEcCtD
Rosiglitazone—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00125	CcSEcCtD
Rosiglitazone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000184	0.0049	CbGeAlD
Rosiglitazone—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00124	CcSEcCtD
Rosiglitazone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00123	CcSEcCtD
Rosiglitazone—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00123	CcSEcCtD
Rosiglitazone—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00123	CcSEcCtD
Rosiglitazone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00018	0.00121	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.00121	CcSEcCtD
Rosiglitazone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.00121	CcSEcCtD
Rosiglitazone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00121	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00121	CcSEcCtD
Rosiglitazone—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000178	0.0012	CcSEcCtD
Rosiglitazone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000178	0.0012	CcSEcCtD
Rosiglitazone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00472	CbGeAlD
Rosiglitazone—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.0012	CcSEcCtD
Rosiglitazone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00119	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000176	0.00119	CcSEcCtD
Rosiglitazone—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00119	CcSEcCtD
Rosiglitazone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.00118	CcSEcCtD
Rosiglitazone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.00118	CcSEcCtD
Rosiglitazone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000174	0.00117	CcSEcCtD
Rosiglitazone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00117	CcSEcCtD
Rosiglitazone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000174	0.00117	CcSEcCtD
Rosiglitazone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000173	0.00117	CcSEcCtD
Rosiglitazone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.00116	CcSEcCtD
Rosiglitazone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000172	0.00116	CcSEcCtD
Rosiglitazone—PTGS1—brain—acquired immunodeficiency syndrome	0.000171	0.00456	CbGeAlD
Rosiglitazone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00116	CcSEcCtD
Rosiglitazone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00116	CcSEcCtD
Rosiglitazone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.00115	CcSEcCtD
Rosiglitazone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.00115	CcSEcCtD
Rosiglitazone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00017	0.00115	CcSEcCtD
Rosiglitazone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000169	0.00114	CcSEcCtD
Rosiglitazone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00114	CcSEcCtD
Rosiglitazone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00114	CcSEcCtD
Rosiglitazone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00114	CcSEcCtD
Rosiglitazone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00114	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000167	0.00113	CcSEcCtD
Rosiglitazone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000167	0.00113	CcSEcCtD
Rosiglitazone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000167	0.00113	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00113	CcSEcCtD
Rosiglitazone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00112	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000166	0.0044	CbGeAlD
Rosiglitazone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000165	0.00112	CcSEcCtD
Rosiglitazone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00112	CcSEcCtD
Rosiglitazone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00111	CcSEcCtD
Rosiglitazone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000164	0.00111	CcSEcCtD
Rosiglitazone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000164	0.00111	CcSEcCtD
Rosiglitazone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000164	0.00111	CcSEcCtD
Rosiglitazone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.0011	CcSEcCtD
Rosiglitazone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.0011	CcSEcCtD
Rosiglitazone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.0011	CcSEcCtD
Rosiglitazone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.00109	CcSEcCtD
Rosiglitazone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000161	0.00109	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00108	CcSEcCtD
Rosiglitazone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.00107	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00107	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00107	CcSEcCtD
Rosiglitazone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000158	0.00107	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.00107	CcSEcCtD
Rosiglitazone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.00106	CcSEcCtD
Rosiglitazone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.00106	CcSEcCtD
Rosiglitazone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000156	0.00106	CcSEcCtD
Rosiglitazone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000156	0.00105	CcSEcCtD
Rosiglitazone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000156	0.00105	CcSEcCtD
Rosiglitazone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.00105	CcSEcCtD
Rosiglitazone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000155	0.00105	CcSEcCtD
Rosiglitazone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00105	CcSEcCtD
Rosiglitazone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00105	CcSEcCtD
Rosiglitazone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.00104	CcSEcCtD
Rosiglitazone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00104	CcSEcCtD
Rosiglitazone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00103	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00103	CcSEcCtD
Rosiglitazone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000151	0.00102	CcSEcCtD
Rosiglitazone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00015	0.00102	CcSEcCtD
Rosiglitazone—Headache—Stavudine—acquired immunodeficiency syndrome	0.00015	0.00101	CcSEcCtD
Rosiglitazone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.00101	CcSEcCtD
Rosiglitazone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00101	CcSEcCtD
Rosiglitazone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000149	0.001	CcSEcCtD
Rosiglitazone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000148	0.001	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.001	CcSEcCtD
Rosiglitazone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.001	CcSEcCtD
Rosiglitazone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000148	0.000998	CcSEcCtD
Rosiglitazone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000997	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000995	CcSEcCtD
Rosiglitazone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000147	0.000995	CcSEcCtD
Rosiglitazone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000994	CcSEcCtD
Rosiglitazone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000984	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000982	CcSEcCtD
Rosiglitazone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000981	CcSEcCtD
Rosiglitazone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000963	CcSEcCtD
Rosiglitazone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000962	CcSEcCtD
Rosiglitazone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000142	0.00096	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000958	CcSEcCtD
Rosiglitazone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000141	0.00374	CbGeAlD
Rosiglitazone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000946	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000943	CcSEcCtD
Rosiglitazone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000942	CcSEcCtD
Rosiglitazone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000939	CcSEcCtD
Rosiglitazone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000938	CcSEcCtD
Rosiglitazone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000934	CcSEcCtD
Rosiglitazone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000929	CcSEcCtD
Rosiglitazone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000925	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000914	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000908	CcSEcCtD
Rosiglitazone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000907	CcSEcCtD
Rosiglitazone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000899	CcSEcCtD
Rosiglitazone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000894	CcSEcCtD
Rosiglitazone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000886	CcSEcCtD
Rosiglitazone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000886	CcSEcCtD
Rosiglitazone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000885	CcSEcCtD
Rosiglitazone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.00088	CcSEcCtD
Rosiglitazone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000874	CcSEcCtD
Rosiglitazone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000868	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000866	CcSEcCtD
Rosiglitazone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000865	CcSEcCtD
Rosiglitazone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000864	CcSEcCtD
Rosiglitazone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000858	CcSEcCtD
Rosiglitazone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000848	CcSEcCtD
Rosiglitazone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000845	CcSEcCtD
Rosiglitazone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000836	CcSEcCtD
Rosiglitazone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000835	CcSEcCtD
Rosiglitazone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.000835	CcSEcCtD
Rosiglitazone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000824	CcSEcCtD
Rosiglitazone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000823	CcSEcCtD
Rosiglitazone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000819	CcSEcCtD
Rosiglitazone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000817	CcSEcCtD
Rosiglitazone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000808	CcSEcCtD
Rosiglitazone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000797	CcSEcCtD
Rosiglitazone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000784	CcSEcCtD
Rosiglitazone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000781	CcSEcCtD
Rosiglitazone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000779	CcSEcCtD
Rosiglitazone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000778	CcSEcCtD
Rosiglitazone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000776	CcSEcCtD
Rosiglitazone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000774	CcSEcCtD
Rosiglitazone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000773	CcSEcCtD
Rosiglitazone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000754	CcSEcCtD
Rosiglitazone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000748	CcSEcCtD
Rosiglitazone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000745	CcSEcCtD
Rosiglitazone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000744	CcSEcCtD
Rosiglitazone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000744	CcSEcCtD
Rosiglitazone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.00074	CcSEcCtD
Rosiglitazone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000733	CcSEcCtD
Rosiglitazone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000722	CcSEcCtD
Rosiglitazone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00072	CcSEcCtD
Rosiglitazone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.00072	CcSEcCtD
Rosiglitazone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.00071	CcSEcCtD
Rosiglitazone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000702	CcSEcCtD
Rosiglitazone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000695	CcSEcCtD
Rosiglitazone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000689	CcSEcCtD
Rosiglitazone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000688	CcSEcCtD
Rosiglitazone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000686	CcSEcCtD
Rosiglitazone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000684	CcSEcCtD
Rosiglitazone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000663	CcSEcCtD
Rosiglitazone—Rash—Saquinavir—acquired immunodeficiency syndrome	9.81e-05	0.000663	CcSEcCtD
Rosiglitazone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.8e-05	0.000662	CcSEcCtD
Rosiglitazone—Headache—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.000659	CcSEcCtD
Rosiglitazone—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.6e-05	0.000649	CcSEcCtD
Rosiglitazone—Rash—Lamivudine—acquired immunodeficiency syndrome	9.36e-05	0.000633	CcSEcCtD
Rosiglitazone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.35e-05	0.000632	CcSEcCtD
Rosiglitazone—Headache—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000628	CcSEcCtD
Rosiglitazone—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.24e-05	0.000625	CcSEcCtD
Rosiglitazone—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.000596	CcSEcCtD
